LAMB2 and cancer: LAMC1 binds to integrin (ITGA3-ITGB1) receptors, inducing the activation of the laminin signaling pathway, further leading to the formation of extracellular matrix, hindering the recruitment of immune effector cells into the TME to exert anti-cancer effects.